Long COVID has become a world-wide, non-communicable epidemic, caused by long-
lasting multiorgan symptoms that endure for weeks or months after SARS-CoV-2 infection …

Scope The aim of these guidelines is to provide evidence-based recommendations for the
assessment and management of individuals with persistent symptoms after acute COVID-19 …

Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute
respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 …

Background Health-related quality of life (HRQoL) impairment is often reported among
COVID-19 ICU survivors, and little is known about their long-term outcomes. We evaluated …

Since the Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), our understanding regarding the …

The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

As of October 2021, SARS-CoV-2 infections were reported among 512,613 children and
adolescents in Israel (~ 33% of all COVID-19 cases). The 5–11-year age group accounted …

Post-COVID-19 condition refers to a range of persisting physical, neurocognitive, and
neuropsychological symptoms following SARS-CoV-2 infection. Recent evidence revealed …

COVID-19 has shown significant morbidity with the involvement of multiple systems,
including the cardiovascular system. Cardiovascular manifestations in the acute phase can …

The emergence of persistent symptoms following SARS-CoV-2 infection, known as long
COVID, is providing a new challenge to healthcare systems. The cardinal features are …